Pressmeddelanden

Clarification: PILA PHARMA SPONSORS INTERNATIONAL DIABETES & NUTRITION CONFERENCE Dispatch missing first section with scientific meeting information. PILA PHARMA today announces it's participation in and co-sponsorship of the 41st International Symposium on D...
PILA PHARMA SPONSORS INTERNATIONAL DIABETES & NUTRITION CONFERENCE PILA PHARMA today announces it's participation in and co-sponsorship of the 41st International Symposium on Diabetes and Nutrition, organized by the Diabetes and Nutrition Study...
PILA PHARMA PRESENTS TOMORROW AT "AKTIESPARARNA" PILA PHARMA AB (publ) (FN STO: PILA) announces that it will present tomorrow at the Aktiespararna's "Store Aktiedagarna" event.
PILA PHARMA PRESENTS TODAY AT REDEYE THEME: DIABETES PILA PHARMA AB (publ) (FN STO: PILA) announces that it will present today at the Redeye Theme: Diabetes.
CEO Gustav H. Gram increases holding in Pila Pharma AB Pila Pharma AB (publ) (FN STO: PILA) announces that newly appointed CEO Gustav H. Gram has purchased additional shares. The purchases occurred in two tranches: Friday May 10th, w...
PILA PHARMA RECEIVES AWARD OF INNOVATION GRANT Pila Pharma AB (publ) (FN STO: PILA) hereby informs that it has been awarded an innovation grant corresponding to a value of SEK 100.000 to sponsor a further developed IP strateg...
Visa fler pressmeddelanden

Rapporter

Video

Finansiell kalender

Halvårsrapport 2024 Delårsrapport
Bokslutskommuniké 2024 Bokslutskommuniké

Om PILA PHARMA

Prenumerera

Få löpande information från PILA PHARMA via e-post.

Handelsinformation

Kurs ()
Förändring ()
Marknad Nasdaq First North Growth Market Kortnamn PILA ISIN-kod SE0015988274 Certified Adviser Aqurat Fondkommission